Medistim ASA (0OCD) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medistim Asa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.063 and welcome to Medisim's first quarter 2025 results presentation. 00:00:06.063 -- 00:00:11.153 My name is Kari Kragstad, and together with the CFO, Thomas Jakobsen, we are going 00:00:11.153 -- 00:00:15.137 to take you through the first quarter's results. 00:00:16.450 -- 00:00:21.702 And we will start with the highlights. But before that, we like 00:00:21.702 -- 00:00:26.994 to also remind everyone of Medistim's track record, which has been very positive, showing 00:00:26.994 -- 00:00:32.106 a consistent delivery of sales growth, profitable sales growth over the 00:00:32.106 -- 00:00:38.372 years. And as the last 12 months 2025 00:00:38.372 -- 00:00:42.379 columns are indicating, we can already from this graph 00:00:42.379 -- 00:00:47.447 disclose that Q1 was a very strong start to 2025 for the 00:00:47.447 -- 00:00:49.049 company. 00:00:49.049 -- 00:00:53.733 So let's go directly into the highlights for the first quarter. 00:00:55.415 -- 00:01:01.305 This is really a quarter when the business is firing on all cylinders. 00:01:01.305 -- 00:01:06.333 It is an exceptionally strong sales and EBIT for a quarter, representing a new 00:01:06.333 -- 00:01:09.094 record for both. 181.5 00:01:10.500 -- 00:01:13.866 million NOX in revenues. That's actually 20% 00:01:13.866 -- 00:01:18.854 higher than our previous record, which we set in the fourth quarter last year. 00:01:18.854 -- 00:01:23.358 So that ends up with a 35.7% 00:01:23.542 -- 00:01:27.606 growth in total, which is of course extremely high. 00:01:27.850 -- 00:01:32.058 We see that we have a little bit help from currency, but still adjusting for that, the 00:01:32.058 -- 00:01:35.540 total sales is up 31.8%. 00:01:36.185 -- 00:01:39.932 And as I said, it's really firing on all cyl...